|
| | SB2787 Enrolled | - 2 - | LRB099 16154 MLM 40480 b |
|
|
1 | | (2) the number of requests for external review resolved |
2 | | and, of those resolved, the number resolved upholding the |
3 | | adverse determination or final adverse determination and |
4 | | the number resolved reversing the adverse determination or |
5 | | final adverse determination; |
6 | | (3) the average length of time for resolution; |
7 | | (4) a summary of the types of coverages or cases for |
8 | | which an external review was sought, as provided in the |
9 | | format required by the Director; |
10 | | (5) the number of external reviews that were terminated |
11 | | as the result of a reconsideration by the health carrier of |
12 | | its adverse determination or final adverse determination |
13 | | after the receipt of additional information from the |
14 | | covered person or the covered person's authorized |
15 | | representative; and |
16 | | (6) any other information the Director may request or |
17 | | require. |
18 | | (a-15) The independent review organization shall retain |
19 | | the written records required pursuant to this Section for at |
20 | | least 3 years. |
21 | | (b) The report required under subsection (a) of this |
22 | | Section shall include in the aggregate, by state, and by type |
23 | | of health benefit plan:
|
24 | | (1) the total number of requests for external review; |
25 | | (2) the total number of requests for expedited external |
26 | | review;
|
|
| | SB2787 Enrolled | - 3 - | LRB099 16154 MLM 40480 b |
|
|
1 | | (3) the total number of requests for external review |
2 | | denied; |
3 | | (4) the number of requests for external review |
4 | | resolved, including: |
5 | | (A) the number of requests for external review |
6 | | resolved upholding the adverse determination or final |
7 | | adverse determination; |
8 | | (B) the number of requests for external review |
9 | | resolved reversing the adverse determination or final |
10 | | adverse determination; |
11 | | (C) the number of requests for expedited external |
12 | | review resolved upholding the adverse determination or |
13 | | final adverse determination; and |
14 | | (D) the number of requests for expedited external |
15 | | review resolved reversing the adverse determination or |
16 | | final adverse determination; |
17 | | (5) the average length of time for resolution for an |
18 | | external review; |
19 | | (6) the average length of time for resolution for an |
20 | | expedited external review; |
21 | | (7) a summary of the types of coverages or cases for |
22 | | which an external review was sought, as specified below:
|
23 | | (A) denial of care or treatment (dissatisfaction |
24 | | regarding prospective non-authorization of a request |
25 | | for care or treatment recommended by a provider |
26 | | excluding diagnostic procedures and referral requests; |
|
| | SB2787 Enrolled | - 4 - | LRB099 16154 MLM 40480 b |
|
|
1 | | partial approvals and care terminations are also |
2 | | considered to be denials); |
3 | | (B) denial of diagnostic procedure |
4 | | (dissatisfaction regarding prospective |
5 | | non-authorization of a request for a diagnostic |
6 | | procedure recommended by a provider; partial approvals |
7 | | are also considered to be denials); |
8 | | (C) denial of referral request (dissatisfaction |
9 | | regarding non-authorization of a request for a |
10 | | referral to another provider recommended by a PCP); |
11 | | (D) claims and utilization review (dissatisfaction |
12 | | regarding the concurrent or retrospective evaluation |
13 | | of the coverage, medical necessity, efficiency or |
14 | | appropriateness of health care services or treatment |
15 | | plans; prospective "Denials of care or treatment", |
16 | | "Denials of diagnostic procedures" and "Denials of |
17 | | referral requests" should not be classified in this |
18 | | category, but the appropriate one above);
|
19 | | (8) the number of external reviews that were terminated |
20 | | as the result of a reconsideration by the health carrier of |
21 | | its adverse determination or final adverse determination |
22 | | after the receipt of additional information from the |
23 | | covered person or the covered person's authorized |
24 | | representative; and |
25 | | (9) any other information the Director may request or |
26 | | require.
|